Frédéric Charlotte

1993–2025 年に発表

123
論文数
28,464
被引用数
86
h 指数
119
i10 指数

被引用数

Frédéric Charlotte の年別被引用数1991 年: 被引用 2 件1995 年: 被引用 15 件1996 年: 被引用 5 件1997 年: 被引用 15 件1998 年: 被引用 23 件1999 年: 被引用 26 件2000 年: 被引用 61 件2001 年: 被引用 81 件2002 年: 被引用 139 件2003 年: 被引用 163 件2004 年: 被引用 199 件2005 年: 被引用 226 件2006 年: 被引用 256 件2007 年: 被引用 248 件2008 年: 被引用 285 件2009 年: 被引用 228 件2010 年: 被引用 292 件2011 年: 被引用 233 件2012 年: 被引用 202 件2013 年: 被引用 231 件2014 年: 被引用 285 件2015 年: 被引用 280 件2016 年: 被引用 256 件2017 年: 被引用 264 件2018 年: 被引用 173 件2019 年: 被引用 646 件2020 年: 被引用 713 件2021 年: 被引用 731 件2022 年: 被引用 475 件2023 年: 被引用 327 件2024 年: 被引用 622 件2025 年: 被引用 252 件2026 年: 被引用 9 件1992〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,314 件、この内訳の 24.9%フランス: 引用元論文 940 件、この内訳の 10.1%イタリア: 引用元論文 640 件、この内訳の 6.9%イギリス: 引用元論文 589 件、この内訳の 6.3%中国: 引用元論文 558 件、この内訳の 6%ドイツ: 引用元論文 489 件、この内訳の 5.3%日本: 引用元論文 350 件、この内訳の 3.8%スペイン: 引用元論文 291 件、この内訳の 3.1%カナダ: 引用元論文 258 件、この内訳の 2.8%オーストラリア: 引用元論文 232 件、この内訳の 2.5%スイス: 引用元論文 204 件、この内訳の 2.2%オランダ: 引用元論文 195 件、この内訳の 2.1%
0%24.9%その他 24%

分野

  • Medicine87.2%
  • Immunology and Microbiology5.6%
  • Biochemistry, Genetics and Molecular Biology5.1%
  • Neuroscience0.3%
  • Computer Science0.3%
  • Pharmacology, Toxicology and Pharmaceutics0.3%
  • その他1.2%

トピック

  • Liver Disease Diagnosis and Treatment17.1%
  • Liver Disease and Transplantation5.6%
  • Hepatitis C virus research5.6%
  • Diet, Metabolism, and Disease3.2%
  • Hepatitis B Virus Studies2.5%
  • Liver Diseases and Immunity2.5%
  • その他63.5%

共著者

全論文

検索で開く
  1. Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

    著者: , , , , , , , , - Gastroenterology 2005 被引用: 2,078

  2. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Blood 2016 被引用: 1,561

  3. Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease

    著者: , , , , , , - Alimentary Pharmacology & Therapeutics 2014 被引用: 510

  4. 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Magda El-Monayeri, Paulo Fontes, Emma E. Furth, Annette S.H. Gouw, Sara Hafezi‐Bakhtiari, John Hart, Eva Honsová, W. Ismail, Takeshi Itoh, N. Jhala, Urmila Khettry, Göran B. Klintmalm, Stuart J. Knechtle, T Koshiba, Tomasz Kozłowski, Charles Lassman, Jan Lerut, Josh Levitsky, Lisa Licini, Rosa Liotta, George Mazariegos, Marta I. Minervini, Joseph Misdraji, Thalachallour Mohanakumar, Johan Mölne, Imad Nasser, James Neuberger, Marsha O'Neil, Orit Pappo, L. Petrovič, Phillip Ruiz, Özgül Sağol, A. Sanchez Fueyo, Eizaburo Sasatomi, Abraham Shaked, M. Shiller, Takahiro Shimizu, B. Sis, Aurelio Sonzogni, Heather L. Stevenson, Swan N. Thung, Giuseppe Tisone, Athanassios C. Tsamandas, Annika Wernerson, Ting-Jung Wu, Adriana Zeevi, Yoh Zen - American Journal of Transplantation 2016 被引用: 627

  5. Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jérémy Augustin, Wei Qiang Leow, Howard H.W. Leung, Emmanuel Boleslawski, Mohamed Rela, Arnaud François, Anthony Wing-Hung, Alejandro Forner, María Reig, Manon Allaire, Olivier Scatton, Denis Chatelain, Camille Boulagnon‐Rombi, Nathalie Stürm, Benjamin Menahem, É. Frouin, David Tougeron, Christophe Tournigand, Emmanuelle Kempf, Haeryoung Kim, Massih Ningarhari, Sophie Michalak-Provost, Purva Gopal, Raffaele Brustia, Éric Vibert, Kornelius Schulze, Darius F. Rüther, Sören Weidemann, Rami Rhaiem, Jean–Michel Pawlotsky, Xuchen Zhang, Alain Luciani, Sebastien Mulé, Alexis Laurent, Giuliana Amaddeo, Hélène Regnault, Eléonora De Martin, Christine Sempoux, Pooja Navale, Maria Westerhoff, Regina Cheuk‐Lam Lo, Jan Bednarsch, Annette Gouw, Catherine Guettier, Marie Lequoy, Kenichi Harada, Pimsiri Sripongpun, Poowadon Wetwittayaklang, Nicolas Loménie, Jarukit Tantipisit, Apichat Kaewdech, Jeanne Shen, Valérie Paradis, Stefano Caruso, Jakob Nikolas Kather - Nature Communications 2023 被引用: 77

  6. Management and outcome of primary CNS lymphoma in the modern era

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Corinne Haïoun, Safia Chebrek, Anna Schmitt, Marie Blonski, Roch Houot, Eileen M. Boyle, Jacques‐Olivier Bay, Lucie Obéric, Émeline Tabouret, Agathe Waultier, N. Martin–Duverneuil, Valérie Touitou, Nathalie Cassoux, Aurélie Kas, Karima Mokhtari, Frédéric Charlotte, Agustí Alentorn, L. Feuvret, Magali Le Garff‐Tavernier, Myrto Costopoulos, Bertrand Mathon, Matthieu Peyre, Daniel Delgadillo, Hassen Douzane, Diane Genet, Bachir Aidaoui, Khê Hoang‐Xuan, Emmanuel Gyan - Neurology 2020 被引用: 245

  7. Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial

    著者: , , , , , , , , , , , - Gastroenterology 2008 被引用: 622

  8. Altered X-chromosome inactivation predisposes to autoimmunity

    著者: , , , , , , , , , , - Science Advances 2024 被引用: 60

  9. Persistence of severe liver fibrosis despite substantial weight loss with bariatric surgery

    著者: , , , , , , , , , , - Hepatology 2022 被引用: 79

  10. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver

    著者: , , , , , , - Journal of Hepatology 2013 被引用: 522

  11. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

    著者: , , , , , , , , , , , , , , , , , , , , , , - Blood 2012 被引用: 693

  12. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease

    著者: , , , , , , , , , , , , , , , , , - Blood 2018 被引用: 624

  13. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

    著者: , , , , , - The Lancet 2001 被引用: 1,443

  14. Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study)

    著者: , , , , , , , , , , , - Blood 2017 被引用: 206

  15. Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Françoise Berger, Céline Bossard, Flavie Arbion, Isabelle Quintin‐Roué, Jean‐Michel Picquenot, Martine Patey, Blandine Fabre, Henri Sevestre, Cécile Le Naourès, Marie-Pierre Chenard-Neu, Claire Bastien, S. Thiebault, Laurent Martin, Manuela Delage, Thomas Filleron, Gilles Salles, Thierry Jo Molina, Georges Delsol, Pierre Brousset, Philippe Gaulard - Journal of Clinical Oncology 2017 被引用: 217

  16. Molecular and clinical diversity in primary central nervous system lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chip Stewart, Aurélien de Reyniès, Sylvain Choquet, Carole Soussain, Caroline Houillier, Bjoern Chapuy, Khê Hoang‐Xuan, Agustí Alentorn - Annals of Oncology 2022 被引用: 83

  17. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

    著者: , , , , , , , , , , , , , - Comparative Hepatology 2005 被引用: 361

  18. High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis

    著者: , , , , , , , , , , , , , , , , , , , , , , - Blood 2017 被引用: 147

  19. Liver fibrosis in overweight patients

    著者: , , , , , , , , , - Gastroenterology 2000 被引用: 971

  20. The Integrase Inhibitors Dolutegravir and Raltegravir Exert Proadipogenic and Profibrotic Effects and Induce Insulin Resistance in Human/Simian Adipose Tissue and Human Adipocytes

    著者: , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2020 被引用: 146

  21. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia

    著者: , , , , , , - Journal of Clinical Investigation 2003 被引用: 481

  22. Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease

    著者: , , , , , , , - Journal of Hepatology 2019 被引用: 83

  23. Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease

    著者: , , , , , , , , , , - BMJ Open Gastroenterology 2016 被引用: 117

  24. Hepatic stellate cell hypertrophy is associated with metabolic liver fibrosis

    著者: , , , , , , , , , , , , , , , , - Scientific Reports 2020 被引用: 78